- Home
- TDS vs LNTH Comparison
TDS vs LNTH Comparison
Compare TDS & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TDS
- LNTH
- Stock Information
- Founded
- TDS 1968
- LNTH 1956
- Country
- TDS United States
- LNTH United States
- Employees
- TDS N/A
- LNTH N/A
- Industry
- TDS Telecommunications Equipment
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- TDS Telecommunications
- LNTH Health Care
- Exchange
- TDS Nasdaq
- LNTH Nasdaq
- Market Cap
- TDS 4.4B
- LNTH 3.6B
- IPO Year
- TDS N/A
- LNTH 2015
- Fundamental
- Price
- TDS $40.08
- LNTH $54.86
- Analyst Decision
- TDS Buy
- LNTH Strong Buy
- Analyst Count
- TDS 2
- LNTH 6
- Target Price
- TDS $52.00
- LNTH $105.50
- AVG Volume (30 Days)
- TDS 1.4M
- LNTH 2.6M
- Earning Date
- TDS 08-11-2025
- LNTH 08-06-2025
- Dividend Yield
- TDS 0.40%
- LNTH N/A
- EPS Growth
- TDS N/A
- LNTH N/A
- EPS
- TDS N/A
- LNTH 3.77
- Revenue
- TDS $4,805,000,000.00
- LNTH $1,520,653,000.00
- Revenue This Year
- TDS N/A
- LNTH N/A
- Revenue Next Year
- TDS $0.49
- LNTH $3.24
- P/E Ratio
- TDS N/A
- LNTH $14.55
- Revenue Growth
- TDS N/A
- LNTH 5.75
- 52 Week Low
- TDS $21.81
- LNTH $47.25
- 52 Week High
- TDS $42.74
- LNTH $118.21
- Technical
- Relative Strength Index (RSI)
- TDS 61.25
- LNTH 38.69
- Support Level
- TDS $38.52
- LNTH $55.01
- Resistance Level
- TDS $40.29
- LNTH $60.14
- Average True Range (ATR)
- TDS 1.15
- LNTH 2.04
- MACD
- TDS 0.08
- LNTH 0.75
- Stochastic Oscillator
- TDS 94.18
- LNTH 57.70
About TDS Telephone and Data Systems Inc.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides mobile, telephone, and broadband services. The company's segments include UScellular Wireless, UScellular Towers, and TDS Telecom. It generates maximum revenue from the UScellular Wireless segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.